Faster drug discovery? Startup develops more cost-effective test for assessing how cells respond to chemicals

For pharmaceutical firms, gene-expression profiling has become a valuable tool for drug discovery. This process involves measuring the activity of a cell's genes in response to drugs, to determine the compounds' effectiveness, toxicity, and other characteristics. Conventional profiling methods, however, are inefficient or expensive, sometimes costing millions of dollars.

Read the whole article on Physorg

More from Physorg